ArticleJournal of experimental & clinical cancer research : CR2024

Auranofin repurposing for lung and pancreatic cancer: low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by AKT inhibition.

Christophe Deben et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.